| # | % | |||||
|---|---|---|---|---|---|---|
| 151 | SPARK THERAPEUTICS INCORPORATED | 4,847 | 242,000 | 0.07% | ||
| 152 | RIGEL PHARMACEUTICAL INC | 101,628 | 242,000 | 0.07% | ||
| 153 | AVEXIS INC COM | 5,049 | 241,000 | 0.07% | ||
| 154 | TORONTO DOMINION BK ONT | 245,000 | 241,000 | 0.07% | ||
| 155 | CELLDEX THERAPEUTICS INC NEW | 68,024 | 241,000 | 0.07% | ||
| 156 | TG THERAPEUTICS INC COM | 51,122 | 238,000 | 0.07% | ||
| 157 | KITE PHARMA INCORPORATED | 5,313 | 238,000 | 0.07% | ||
| 158 | PROTHENA CORP PLC | 4,795 | 236,000 | 0.07% | ||
| 159 | RADIUS HEALTH INCORPORATED COM NEW | 6,130 | 233,000 | 0.07% | ||
| 160 | AIMMUNE THERAPEUTICS INC COM | 11,276 | 231,000 | 0.07% | ||
| 161 | NEUROCRINE BIOSCIE COM USD0.001 | 5,854 | 227,000 | 0.07% | ||
| 162 | GLOBAL BLOOD THERAPEUTICS INCORPORATED | 15,719 | 227,000 | 0.07% | ||
| 163 | LEXICON PHARMACEUTICALS INC | 16,410 | 227,000 | 0.07% | ||
| 164 | BLUEBIRD BIO INC COM | 3,667 | 226,000 | 0.07% | ||
| 165 | PUMA BIOTECHNOLOGY | 7,366 | 226,000 | 0.07% | ||
| 166 | ACCELERON PHARMA INC | 8,771 | 224,000 | 0.07% | ||
| 167 | PTC THERAPEUTICS INC | 20,523 | 224,000 | 0.07% | ||
| 168 | MINERVA NEUROSCIENCES INC COM | 18,814 | 221,000 | 0.07% | ||
| 169 | ALNYLAM PHARMACEUTICALS INC | 5,857 | 219,000 | 0.07% | ||
| 170 | ZIOPHARM ONCOLOGY INC | 40,359 | 216,000 | 0.06% | ||
| 171 | AMICUS THERAPEUTICS INC COM | 43,256 | 215,000 | 0.06% | ||
| 172 | AGIOS PHARMACEUTICALS INC | 4,764 | 199,000 | 0.06% | ||
| 173 | VANGUARD WORLD FD | 1,465 | 186,000 | 0.06% | ||
| 174 | WILLIAMS COS INC DEL | 4,619 | 144,000 | 0.04% | ||
| 175 | CEMPRA INC | 35,893 | 101,000 | 0.03% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-17-002356, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
